Prescription drug · NDA
Veppanu (Vepdegestrant) NDC 84043-100
Vepdegestrant 100 mg/1 · Tablet · Oral · Arvinas Operations, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 84043-100-30 | 84043010030 | 30 TABLET in 1 BOTTLE (84043-100-30)Marketed from May 1, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Veppanu
- Generic name (nonproprietary)
- vepdegestrant
- Active ingredients
- Vepdegestrant — 100 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Arvinas Operations, Inc.NDC labeler code 84043
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 219835
- Marketing start
- Listing expires
- Identifiers
- Product ID 84043-100_35775ae7-f00d-1c21-e063-6294a90a914cSPL ID 35775ae7-f00d-1c21-e063-6294a90a914cSPL set ID 751e18d5-1d41-4b67-b1f3-10272ca5312dRxCUI 2743355, 2743361, 2743363, 2743365UNII WC1U3R1YMI
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N484043010030followed by a unit qualifier and the quantityPackage 84043-0100-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
VEPPANU is indicated for the treatment of adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, estrogen receptor-1 (ESR1) -mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy. VEPPANU is a heterobifunctional protein degrader indicated for the treatment of adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, estrogen receptor-1 ( ESR1) -mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine ther…
Excerpt only. Read the full label for complete information.
About NDC 84043-100
- What is NDC 84043-100?
- 84043-100 is the product NDC for Veppanu (vepdegestrant), Vepdegestrant 100 mg/1 tablet, listed with the FDA by Arvinas Operations, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Veppanu (Vepdegestrant).
- What is the active ingredient?
- Vepdegestrant.
- Who is the labeler?
- Arvinas Operations, Inc., NDC labeler code 84043. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Veppanu?
- 3 other product NDCs are listed under this name. See all Veppanu NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Veppanu products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Veppanuvepdegestrant | Vepdegestrant 100 mg/1 | Tablet, Film coatedOral | Rigel Pharmaceuticals, Inc. | 71332-007 | 71332-0007-30 |
| Veppanuvepdegestrant | Vepdegestrant 200 mg/1 | Tablet, Film coatedOral | Rigel Pharmaceuticals, Inc. | 71332-008 | 71332-0008-30 |
| Veppanuvepdegestrant | Vepdegestrant 200 mg/1 | TabletOral | Arvinas Operations, Inc. | 84043-200 | 84043-0200-30 |
Other NDCs under NDA 219835
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Veppanuvepdegestrant | Vepdegestrant 100 mg/1 | Tablet, Film coatedOral | Rigel Pharmaceuticals, Inc. | 71332-007 |
| Veppanuvepdegestrant | Vepdegestrant 200 mg/1 | Tablet, Film coatedOral | Rigel Pharmaceuticals, Inc. | 71332-008 |
| Veppanuvepdegestrant | Vepdegestrant 200 mg/1 | TabletOral | Arvinas Operations, Inc. | 84043-200 |